Effect of low-level 1800 MHz radiofrequency radiation on the rat sciatic nerve and the protective role of paricalcitol.
Sign Up to like & getrecommendations! Published in 2018 at "Bioelectromagnetics"
DOI: 10.1002/bem.22149
Abstract: The nervous system is an important target of radiofrequency (RF) radiation exposure since it is the excitable component that is potentially able to interact with electromagnetic fields. The present study was designed to investigate the… read more here.
Keywords: radiofrequency radiation; paricalcitol; nerve; sciatic nerve ... See more keywords
Efecto regulador de paricalcitol sobre parámetros inflamatorios, fibróticos y anticalcificantes en el paciente con enfermedad renal crónica. Más allá de la regulación de la enfermedad óseo-mineral
Sign Up to like & getrecommendations! Published in 2020 at "Nefrologia"
DOI: 10.1016/j.nefro.2019.08.001
Abstract: Resumen Antecedentes La principal causa de morbimortalidad en el paciente con enfermedad renal cronica (ERC) es la cardiovascular. La inflamacion y las alteraciones en el metabolismo oseo-mineral en estos pacientes conllevan aumento del riesgo cardiovascular.… read more here.
Keywords: paricalcitol; con; con enfermedad; los ... See more keywords
MO808THE IMPACT OF PARICALCITOL FOR PARATHYROID GLAND SIZE OF SHPT PATIENTS WITH LONG-TERM MAINTENANCE HEMODIALYSIS: AN OBSERVATIONAL STUDY
Sign Up to like & getrecommendations! Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab096.0017
Abstract: This is an observational study to assess effectiveness of paricalcitol for treating secondary hyperparathyroidism (SHPT) patients with long-term maintenance hemodialysis, via changes in biochemical indexes, such as Calcium (Ca), Phosphate (P) and Parathyroid Hormone (PTH),… read more here.
Keywords: maintenance hemodialysis; paricalcitol; long term; term maintenance ... See more keywords
Paricalcitol and Peritoneal Protein Loss in Peritoneal Dialysis: A Double-Center Study
Sign Up to like & getrecommendations! Published in 2018 at "Blood Purification"
DOI: 10.1159/000488637
Abstract: Background/Aims: Peritoneal protein loss (PPL) is associated with cardiovascular disease and mortality in peritoneal dialysis (PD). Controversial results have been published about the effect of paricalcitol in PPL among PD patients. This study intends to… read more here.
Keywords: paricalcitol; ppl; peritoneal protein; peritoneal dialysis ... See more keywords
Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2017 at "BMC Nephrology"
DOI: 10.1186/s12882-017-0691-6
Abstract: BackgroundSecondary hyperparathyroidism (SHPT) is a severe complication for dialysis patients. Vitamin D receptor activators (VDRAs) are used to treat SHPT, but the comparative efficacy and safety between paricalcitol and other vitamin D receptor activators for… read more here.
Keywords: paricalcitol; vitamin receptor; receptor activators; dialysis patients ... See more keywords
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0243759
Abstract: Following a successful renal transplantation circulating markers of inflammation may remain elevated, and systemic inflammation is associated with worse clinical outcome in renal transplant recipients (RTRs). Vitamin D-receptor (VDR) activation is postulated to modulate inflammation… read more here.
Keywords: paricalcitol; markers inflammation; renal transplant; effect paricalcitol ... See more keywords
Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2019.00040
Abstract: Introduction: Secondary hyperparathyroidism (sHPT) is a common hormonal complication of chronic kidney disease. There are several therapeutic options for sHPT management aiming at calcium-phosphorus balance normalization and decrease of parathormone secretion. Objectives: The aim of… read more here.
Keywords: paricalcitol; treatment; group; level ... See more keywords
Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation
Sign Up to like & getrecommendations! Published in 2022 at "Healthcare"
DOI: 10.3390/healthcare11010072
Abstract: Introduction: secondary hyperparathyroidism (SHP) is frequent in patients with chronic kidney disease (CKD), particularly in those in dialysis. To treat this complication, the current options available include phosphorus restriction, phosphate binders, the inhibition of parathyroid… read more here.
Keywords: chronic kidney; paricalcitol; kidney disease; etelcalcetide paricalcitol ... See more keywords
Paricalcitol inhibits the Wnt/beta-catenin signaling pathway and ameliorates experimentally induced arthritis
Sign Up to like & getrecommendations! Published in 2018 at "Turkish journal of medical sciences"
DOI: 10.3906/sag-1804-62
Abstract: Background/aim: The Wnt/ß-catenin pathway has important biological activities, including the differentiation of cells and joint formations. The aim of our study was to determine the effect of paricalcitol on experimentally induced arthritis. Materials and methods:… read more here.
Keywords: paricalcitol; catenin; group; pathway ... See more keywords